PLA2G2A and heart failure: Collectively, the integration of gene-targeted drug prediction and ceRNA network analysis highlights a set of compounds with plausible mechanistic links to AA metabolism—through COX inhibition, PLA2 suppression, or modulation of the CYP/epoxide balance—and provides new avenues for optimizing drug selection and repurposing strategies in heart failure.